1
Views
5
CrossRef citations to date
0
Altmetric
Gene Expression

c-Ha-ras Gene Bidirectional Promoter Expressed In Vitro: Location and Regulation

, , &
Pages 3758-3770 | Received 23 Mar 1989, Accepted 07 Jun 1989, Published online: 31 Mar 2023

LITERATURE CITED

  • Allan, M., and J. Paul. 1984. Transcription in vivo of an Alu family upstream from the human ε-globin gene. Nucleic Acids Res. 12:1193–1200.
  • Allan, M., J. Zhu, P. Montague, and J. Paul. 1984. Differential response of multiple ε-globin cap sites to cis and trans acting controls. Cell 38:399–407.
  • Bar-Segi, D., and J. R. Feramisco. 1985. Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation. Cell 42:841–848.
  • Berk, A. J., and P. A. Sharp. 1977. Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids. Cell 12:721–732.
  • Birchmeier, H. C., D. Broek, and M. Wigler. 1985. Ras proteins can induce meiosis in Xenopus oocytes. Cell 43:615–621.
  • Bos, J. L., E. R. Fearon, S. R. Hamilton, M. Verlan-de Vries, J. H. van Boom, A. J. van der Eb, and B. Vogelstein. 1987. Prevalence of ras gene mutations in human colonrectal cancers. Nature (London) 327:293–297.
  • Bos, J. L., D. Toksoz, C. J. Marshall, M. Verlan-de Vries, G. H. Veeneman, A. J. van der Eb, J. H. van Boom, J. W. Janssen, and A. C. Steenvoorden. 1985. Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukemia. Nature (London) 315:726–730.
  • Bos, J. L., M. Verlan-de Vries, C. J. Marshall, G. H. Veeneman, J. H. van Boom, and A. J. van der Eb. 1986. A human gastric carcinoma contains a single mutated and amplified normal allele of the Ki-ras oncogene. Nucleic Acids Res. 14:1209–1207.
  • Broek, D., N. Samily, O. Fasano, A. Fujiyama, F. Tomonoi, J. Northup, and M. Wigler. 1985. Differential activation of yeast adenylate cyclase by wild-type and mutant ras proteins. Cell 46:447–456.
  • Capon, D. J., E. Y. Chen, A. D. Levinson, P. H. Seeburg, and D. V. Goeddel. 1983. Complete nucleotide sequence of the T24 human bladder carcinoma oncogene and its normal homologue. Nature (London) 302:33–37.
  • Capon, D. J., P. H. Seeburg, J. P. McGrath, J. S. Hayflick, L. L. Edman, A. D. Levinson, and D. V. Goeddel. 1983. Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations. Nature (London) 304:507–513.
  • Chang, E. H., M. E. Furth, E. M. Scolnick, and D. R. Lowy. 1982. Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus. Nature (London) 297:479–483.
  • Chang, D. D., J. E. Hixson, and D. A. Clayton. 1986. Minor transcription initiation events indicate that both human mitochondrial promoters function bidirectionally. Mol. Cell. Biol. 6:294–301.
  • Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5295–5299.
  • Cichutek, K., and P. H. Duesberg. 1986. Harvey ras genes transform without mutant codons apparently activated by truncation of a 5′ exon (exon −1). Proc. Natl. Acad. Sci. USA 83:2340–2344.
  • Crouse, G. F., E. J. Leys, R. N. McEwan, E. G. Frayne, and R. E. Kellems. 1985. Analysis of the mouse dhfr promoter region: existence of a divergently transcribed gene. Mol. Cell. Biol. 5:1847–1848.
  • Damante, G., S. Filetti, and B. Rapaport. 1987. Nucleotide sequence and characterization of the 5′ flanking region of the rat H-ras proto-oncogene. Proc. Natl. Acad. Sci. USA 84:774–778.
  • DeFeo-Jones, D., E. M. Scolnick, R. Roller, and R. Dhar. 1983. Ras-related gene sequences identified and isolated from Saccharomyces cerevisiae. Nature (London) 306:707–709.
  • deVilliers, J., L. Olson, J. Banerji, and W. Schaffner. 1982. Analysis of the transcriptional enhancer effect. Cold Spring Harbor Symp. Quant. Biol. 47:911–921.
  • Ellis, R. W., D. DeFeo, J. M. Maryak, H. A. Young, T. Y. Shih, E. H. Chang, D. R. Lowy, and E. M. Scolnick. 1980. Dual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus. J. Virol. 36:408–420.
  • Ellis, R. W., D. DeFeo, T. Y. Shih, M. A. Gonda, H. A. Young, N. Tsuchida, D. R. Lowy, and E. M. Scolnick. 1981. The p21 src genes of Harvey and Kirsten sarcoma virus originate from divergent members of a family of normal vertebrate genes. Nature (London) 292:506–511.
  • Feramisco, J. R., M. Gross, T. Kamata, M. Rosenberg, and R. W. Sweet. 1984. Microinjection of the oncogenic form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell 38:109–117.
  • Gaffney, D. F., J. McLauchlan, J. L. Whitton, and J. B. Clements. 1985. A modular system for the assay of transcription regulatory signals: the sequence TAATGARAT is required for the herpes simplex virus immediate early gene activation. Nucleic Acids Res. 13:7847–7863.
  • Gallick, G. E., R. Kurzrock, W. S. Kloetzer, R. B. Arlinghaus, and J. U. Gutterman. 1985. Expression of p21ras in fresh primary and metastatic human colonrectal tumors. Proc. Natl. Acad. Sci. USA 82:1795–1799.
  • Ghosh, P. K., J. B. Reddy, M. Piatak, P. Lebowitz, and S. M. Weissman. 1980. Determination of RNA sequences by primer directed synthesis and sequencing of their cDNA transcripts. Methods Enzymol. 65:580–595.
  • Gidoni, D., W. S. Dynan, and R. Tjian. 1984. Multiple specific contacts between a mammalian transcription factor and its cognate promoters. Nature (London) 312:409–413.
  • Gidoni, D., J. T. Kadonaga, H. Barrera-Saldana, K. Takahashi, P. Chambon, and R. Tjian. 1985. Bi-directional SV40 transcription mediated by tandem SP1 binding interactions. Science 230:511–517.
  • Gilman, A. G.. 1984. G proteins and dual control of adenylate cyclase. Cell 36:577–579.
  • Gluzman, Y.. 1981. SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23:175–182.
  • Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyl-transferase in mammalian cells. Mol. Cell. Biol. 2:1044–1051.
  • Hagag, N., S. Halegona, and M. Viola. 1986. Inhibition of growth factor-induced differentiation of PC12 cells by microinjection of antibody to ras p21. Nature (London) 319:680–682.
  • Hall, A., and R. Brown. 1985. Human N-ras: cDNA cloning and gene structure. Nucleic Acids Res. 13:5255–5268.
  • Hand, P. H., A. Thor, D. Wunderlich, R. Maurano, A. Caruso, and J. Schlom. 1984. Monoclonal antibodies of pre-defined specificity detect activated ras gene expression in human mammary and colon carcinomas. Proc. Natl. Acad. Sci. USA 81:5227–5231.
  • Honkawa, H., W. Masahashi, S. Hashimoto, and T. Hashimoto-Gotoh. 1987. Identification of the principal promoter sequence of the c-Ha-ras transforming oncogene: deletion analysis of the 5′-flanking region by focus formation assay. Mol. Cell. Biol. 7:2933–2940.
  • Ishii, S., J. T. Kadonaga, R. Tjian, J. N. Brady, G. T. Merlino, and I. Pastan. 1986. Binding of the Sp1 transcription factor by the human Harvey ras1 proto-oncogene promoter. Science 232:1410–1413.
  • Ishii, S., G. T. Merlino, and I. Pastan. 1985. Promoter region of the human Harvey ras proto-oncogene: similarity to the EGF receptor proto-oncogene promoter. Science 230:1378–1381.
  • Kagimoto, M., J. Miyoshi, K. Tashiro, Y. Naito, Y. Sakaki, K. Sueishi, K. Taneka, and T. Imamura. 1985. Isolation and characterization of an activated c-Ha-ras1 gene from a squamous cell lung carcinoma line. Int. J. Cancer 35:809–812.
  • Kim, S. H., J. C. Moores, D. David, J. G. Respess, D. J. Jolly, and T. Friedmann. 1986. The organization of the human HPRT gene. Nucleic Acids Res. 14:3103–3118.
  • Luskey, M., and M. Botchan. 1981. Inhibition of SV40 replication in simian cells by specific pBR322 DNA sequences. Nature (London) 293:79–81.
  • Maniatis, T., E. F. Fritch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
  • Masters, J. N., and G. Attardi. 1985. Discrete human dihydrofolate reductase gene transcripts present in polysomal RNA map with their 5′ ends several hundred nucleotides upstream of the main mRNA start site. Mol. Cell. Biol. 5:493–500.
  • Maxam, A. M., and W. Gilbert. 1980. Sequencing end-labelled DNA with base-specific chemical cleavages. Methods Enzymol. 65:499–560.
  • McGrath, J. P., D. J. Capon, D. V. Goeddel, and A. D. Levinson. 1984. Comparative biochemical properties of normal and activated human ras p21 protein. Nature (London) 310:644–649.
  • McGrath, J. P., D. J. Capon, D. H. Smith, E. Y. Chen, P. H. Seeburg, D. V. Goeddel, and A. D. Levinson. 1983. Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene. Nature (London) 304:501–506.
  • McGrogan, M., C. C. Simonsen, D. T. Smouse, P. J. Farnham, and R. T. Shimke. 1985. Hetereogeneity at the 5′ termini of mouse dihydrofolate reductase mRNAs. Biol. Chem. 260:2307–2314.
  • Mellon, P., V. Parker, Y. Gluzman, and T. Maniatis. 1981. Identification of DNA sequences required for transcription of the human α1-globin gene in a new SV40 host-vector system. Cell 27:279–288.
  • Melton, D. N., D. S. Kaneeki, J. Brennard, and T. C. Laskey. 1984. Structure, expression and mutation of the hypoxanthine phosphoribosyltransferase gene. Proc. Natl. Acad. Sci. USA 81:2147–2151.
  • Mueller, R., D. J. Slamon, E. D. Adamson, J. M. Tremblay, D. Miller, M. J. Cline, and C. M. Verma. 1983. Transcription of c-onc genes c-rasKi and c-fms during mouse development. Mol. Cell. Biol. 3:1062–1069.
  • Mueller, R., D. J. Slamon, J. M. Tremblay, D. Miller, M. J. Cline, and C. M. Verma. 1982. Differential expression of cellular oncogenes during pre- and post-natal development of the mouse. Nature (London) 299:640–644.
  • Mulcahy, L. S., M. R. Smith, and D. W. Stacey. 1985. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature (London) 313:241–243.
  • Neuman-Silberberg, F. S., E. Schejter, F. M. Hoffman, and B. Z. Shilo. 1984. The Drosophila ras oncogenes: structure and nucleotide sequence. Cell 37:1027–1033.
  • Osborne, T. F., J. L. Goldstein, and M. S. Brown. 1985. 5′ end of HMG CoA reductase gene contains sequences responsible for cholesterol-mediated inhibition of transcription. Cell 42:203–212.
  • O'Toole, C. M., S. Povey, P. Hepburn, and L. M. Franks. 1983. Identity of some human bladder cancer cell lines. Nature (London) 301:429–430.
  • Proudfoot, N. J., T. R. Rutherford, and G. A. Partington. 1984. Transcriptional analysis of human zeta globin genes. EMBO J. 3:1533–1540.
  • Reddy, E. P.. 1983. Nucleotide sequence analysis of the T24 human bladder carcinoma oncogene. Science 220:1061–1063.
  • Reymond, C. D., R. H. Gomer, M. C. Mehdy, and R. A. Firtel. 1984. Developmental regulation of a Dictyostelium gene encoding a protein homologous to mammalian ras protein. Cell 39:141–148.
  • Reynolds, G. A., S. K. Basu, T. F. Osborne, D. J. Chin, G. Gil, M. S. Brown, J. L. Goldstein, and K. L. Luskey. 1984. HMG CoA reductase: a negatively regulated gene with unusual promoter and 5′ untranslated regions. Cell 38:275–285.
  • Shih, T. Y., A. Papgeorge, A. Stokes, M. O. Weeks, and E. M. Scolnick. 1980. Guanine nucleotide-binding and autophosphory-lating activities associated with the p21src protein of Harvey murine sarcoma virus. Nature (London) 287:686–691.
  • Shilo, B. Z., and R. A. Weinberg. 1981. DNA sequences homologous to vertebrate oncogenes are conserved in Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 78:6789–6792.
  • Shimizu, K., D. Birnbaum, M. Ruley, O. Fasano, Y. Suard, L. Edlund, E. Taparowsky, M. Goldfarb, and M. Wigler. 1983. Three human transforming genes are related to the viral ras oncogenes. Proc. Natl. Acad. Sci. USA 80:2112–2116.
  • Tanaka, T., D. J. Slamon, H. Battifora, and M. J. Cline. 1986. Expression of p21 ras onco-proteins in human cancers. Cancer Res. 46:1465–1470.
  • Valerio, D., M. G. C. Dugresteyn, B. M. M. Dekker, G. Weeda, T. M. Berrens, L. van der Voorn, H. van Ormondt, and A. H. van der Eb. 1985. Adenosine deaminase: characterization and expression of a gene with a remarkable promoter. EMBO J. 4:437–443.
  • Wasylyk, B., C. Wasylyk, P. Augereau, and P. Chambon. 1983. The SV40 72 bp repeat preferentially potentiates transcription starting from proximal natural or substitute promoter elements. Cell 32:503–514.
  • Weaver, R. F., and C. Weissman. 1979. Mapping of RNA by a modification of the Berk-Sharp procedure: the 5′ termini of the 15S b-globin mRNA precursor and mature 10S b-globin mRNA identical map co-ordinates. Nucleic Acids Res. 6:1175–1193.
  • Weinberg, R. A.. 1985. The action of oncogenes in the cytoplasm and nucleus. Science 230:770–776.
  • Wigler, M., R. Sweet, G. K. Sim, B. Wold, A. Pellicer, E. Lacey, T. Maniatis, S. Silverstein, and R. Axel. 1979. Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell 16:777–785.
  • Willingham, M. C., I. Pastan, T. Y. Shih, and E. M. Scolnick. 1980. Localization of the src gene product of the Harvey strain of MSV to plasma membrane of transformed cells by electron microscope immunocytochemistry. Cell 19:1005–1014.
  • Wood, T. G., M. L. McGready, B. M. Barandy, D. G. Blair, and G. F. van de Woude. 1984. Mouse c-mos oncogene activation is prevented by upstream sequences. Proc. Natl. Acad. Sci. USA 81:7817–7821.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.